naproxen has been researched along with Osteoarthritis, Hip in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, MT; Carrino, JA; Fountaine, RJ; Guermazi, A; Hickman, A; Hochberg, MC; Nakajo, S; Pixton, G; Schnitzer, TJ; Verburg, KM; Viktrup, L; Walsh, DA; West, CR; White, A | 1 |
| Marin, A; Markotic, F; Puljak, L; Tugwell, P; Utrobicic, A; Vrdoljak, D | 1 |
| Brown, MT; Ekman, EF; Greenberg, HS; Schnitzer, TJ; Smith, MD; Spierings, EL; Verburg, KM; West, CR | 1 |
| Annis, KM; Bello, AE; Brown, MT; Ekman, EF; Gimbel, JS; Keller, DS; Smith, MD; Verburg, KM; West, CR | 1 |
| Anzini, M; Belmonte, G; Biava, M; Cheleschi, S; Di Capua, A; Fioravanti, A; Giordani, A; Pascarelli, NA; Sticozzi, C; Valacchi, G | 1 |
| Bacher, J; Bryant, M; Herbert, R; Murray, C; Rao, S; Safdar, N; Sullivan, N | 1 |
| Aguirre, D; Karlsson, J; Pivodic, A; Schnitzer, TJ | 1 |
| Baerwald, C; Duquesroix, B; Ferreira, T; Frayssinet, H; Verdecchia, P | 1 |
| Bond, M; Davis, A; Hawker, G; Lohmander, S | 1 |
| Amante, C; Chen, SL; Choon, D; Chow, CT; De Tora, L; Genti, G; Laurenzi, M; Lu, HS; Moan, A; Myllykangas-Luosujärvi, R; Pasero, G; Rodgers, DB; Sarembock, B; Vrijens, F; Zerbini, CA | 1 |
| Bolin, L; Genti, G; Kalla, A; Lohmander, LS; Malmenäs, M; McKeith, D; Ramos-Remus, C; Svensson, O; Szechinski, J | 1 |
| Bierma-Zeinstra, SM; Hazes, JM; Koes, BW; Pols, HA; Reijman, M; Stricker, BH | 1 |
| Fajutrao, L; Lohmander, LS; Malmenäs, M; Roos, EM; Svensson, O | 1 |
| Benson, GD; Schweinle, JE; Temple, AR; Zinsenheim, JR | 1 |
| de Blécourt, JJ | 1 |
| Azulay, JP; Blin, O; Daumen-Legré, V; Serratrice, G | 1 |
| Neander, G; Samuelson, P; Seideman, P | 1 |
| Atkinson, JP | 1 |
| Bjarnason, I; Hayllar, J | 1 |
| Bensen, WG | 1 |
| Bevirt, T; Makarowski, W; Recker, DP; Zhao, WW | 1 |
| Beaulieu, A; Castro, R; Detora, LM; Gallacher, AE; Leung, AT; Malmstrom, K; Ng, J; Poor, G; Sanchez, M; Sarembock, B | 1 |
| Balblanc, JC; Charlet, C; Mathieu, P; Richard, M; Vignon, E | 1 |
| Conrozier, T; Mathieu, P; Richard, M; Vignon, E | 1 |
2 review(s) available for naproxen and Osteoarthritis, Hip
| Article | Year |
|---|---|
Celecoxib for osteoarthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Female; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Placebos; Quality of Life; Randomized Controlled Trials as Topic | 2017 |
Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience.
Topics: Analgesics; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Humans; Isoenzymes; Joints; Membrane Proteins; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Treatment Outcome | 2000 |
17 trial(s) available for naproxen and Osteoarthritis, Hip
| Article | Year |
|---|---|
Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Antibodies, Monoclonal, Humanized; Celecoxib; Diclofenac; Disease Progression; Double-Blind Method; Female; Fractures, Bone; Fractures, Spontaneous; Humans; Injections, Subcutaneous; Intra-Articular Fractures; Male; Middle Aged; Naproxen; Nerve Growth Factor; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteonecrosis; Treatment Outcome | 2021 |
Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Arthralgia; Arthroplasty, Replacement; Celecoxib; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hypesthesia; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Paresthesia; Pyrazoles; Sulfonamides; Treatment Outcome | 2015 |
Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Naproxen; Ontario; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain Measurement; Patient Safety; Range of Motion, Articular; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2014 |
Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
Topics: Aged; Antirheumatic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naproxen; Nitric Oxide Donors; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2009 |
Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Pain Measurement; Treatment Outcome | 2010 |
Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.
Topics: Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Disability Evaluation; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Nitric Oxide Donors; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2012 |
Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration.
Topics: Aged; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lactones; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Sulfones; Treatment Outcome | 2002 |
A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthalenes; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Peptic Ulcer; Quality of Life; Treatment Outcome | 2005 |
Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36.
Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Health Status Indicators; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Pain Measurement | 2006 |
Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Patient Compliance; Treatment Outcome | 2006 |
Double-blind controlled evaluation of benoxaprofen for treatment of coxarthrosis and gonarthrosis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Double-Blind Method; Humans; Knee Joint; Middle Aged; Naproxen; Osteoarthritis, Hip; Pain; Propionates | 1981 |
[New methods of analysis of gait in the evaluation of the action of anti-inflammatory drugs. Apropos of naproxen].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Female; Gait; Humans; Knee Joint; Male; Mathematical Computing; Middle Aged; Naproxen; Osteoarthritis; Osteoarthritis, Hip; Treatment Outcome | 1993 |
Naproxen and paracetamol compared with naproxen only in coxarthrosis. Increased effect of the combination in 18 patients.
Topics: Acetaminophen; Activities of Daily Living; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Pain | 1993 |
Gastroduodenal tolerability of highly specific cyclo-oxygenase-2 inhibitor.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Gastric Mucosa; Humans; Indans; Isoenzymes; Knee Joint; Male; Membrane Proteins; Naproxen; Osteoarthritis; Osteoarthritis, Hip; Peroxidases; Prostaglandin-Endoperoxide Synthases | 1996 |
Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Constipation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Administration Schedule; Dyspepsia; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis, Hip; Prostaglandin-Endoperoxide Synthases; Sulfonamides | 2002 |
Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
Topics: Cyclooxygenase 2; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Etoricoxib; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Prostaglandin-Endoperoxide Synthases; Pyridines; Safety; Sulfones; Treatment Outcome | 2002 |
[Effects of naproxen (naprosyne) on the metabolism of arthrotic cartilage in man in vivo].
Topics: Acetaminophen; Administration, Oral; Aged; Cartilage, Articular; Female; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Hip; Prospective Studies | 1991 |
6 other study(ies) available for naproxen and Osteoarthritis, Hip
| Article | Year |
|---|---|
Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Cell Survival; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression; Humans; Interleukin-1beta; Matrix Metalloproteinases; Middle Aged; Molecular Structure; Naproxen; NF-kappa B; Nitrates; Osteoarthritis, Hip; Pyrroles | 2015 |
[Paracetamol in knee and hip arthrosis is dispensable].
Topics: Acetaminophen; Diclofenac; Etoricoxib; Humans; Naproxen; Osteoarthritis, Hip; Osteoarthritis, Knee; Pyridines; Sulfones; Treatment Outcome | 2016 |
Idiopathic chondrolysis condition in two young, wild-caught Cynomolgus monkeys (Macaca fascicularis) reared in captivity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage Diseases; Female; Macaca fascicularis; Monkey Diseases; Naproxen; Osteoarthritis, Hip | 2009 |
Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Disease Progression; Female; Follow-Up Studies; Humans; Ibuprofen; Logistic Models; Male; Middle Aged; Naproxen; Netherlands; Osteoarthritis, Hip; Osteoarthritis, Knee; Pharmacies; Piroxicam; Radiography; Risk Factors | 2005 |
A remembrance of Fred, the lowland gorilla.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ape Diseases; Gorilla gorilla; Male; Naproxen; Osteoarthritis; Osteoarthritis, Hip; Shoulder Joint; Treatment Outcome | 1996 |
[Effects of non-steroidal anti-inflammatory drugs on the enzymatic degradation of osteoarthritic cartilage].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cartilage; Endopeptidases; Female; Humans; Male; Metalloendopeptidases; Microbial Collagenase; Middle Aged; Naproxen; Osteoarthritis, Hip | 1990 |